Accretive Health Inc. (NYSE: AH) was downgraded to Perform from Outperform at Oppenheimer.
Alamos Gold Inc. (NYSE: AGI) was reinstated as Buy with a target price of $21 in Canada, which would translate to closer to $20 in U.S. share prices (versus $16.33 current), at BofA/Merrill Lynch.
Cimarex Energy Co. (NYSE: XEC) was raised to Outperform from Market Perform at FBR Capital Markets.
Comcast Corp. (NASDAQ: CMCSA) was reiterated with a Buy rating at BofA/Merrill Lynch, but where the call stands out is that Comcast was added back to the US 1 List of stocks at the firm.
Control4 Corp. (NASDAQ: CTRL) was started as Buy with a $26 price target at BofA/Merrill Lynch.
Halliburton Co. (NYSE: HAL) was reinstated as Buy with a $62 price target at BofA/Merrill Lynch, and remember this one we recently dubbed the current king of the stock buybacks.
Monsanto Co. (NYSE: MON) was raised to Buy from Neutral at UBS.
Qihoo 360 Technology Co. (NYSE: QIHU) was raised to Buy from Hold at Jefferies.
Safe Bulkers Inc. (NYSE: SB) was raised to Buy all the way up from Underperform for a two-notch upgrade, and the price target was raised to $8 from $6, at BofA/Merrill Lynch.
VMware Inc. (NYSE: VMW) was reiterated as Buy with a $106 price target at BofA/Merrill Lynch. Sterne Agee maintained its Neutral rating and Needham reiterated its Buy rating and raised its price target to $100 from $90. These calls are after Monday’s analyst day.
Top Gaining Stocks
Top Losing Stocks